Specific attenuation of purinergic signaling during bortezomib-induced peripheral neuropathy Aug 16, 2017 | 2022, International Journal of Molecular Sciences, Publication - legacy work ‹ Previous A Novel UPLC-MS Metabolomic Analysis-Based Strategy to Monitor the Course and Extent of iPSC Differentiation to Hepatocytes Next › Directed differentiation of human induced pluripotent stem cells to hepatic stellate cells
